Ramos EL - Search Results

1

Early experience with anti-Tac in clinical renal transplantation.

Kirkman RL, Shapiro ME, Carpenter CB, Milford EL, Ramos EL, Tilney NL, Waldmann TA, Zimmerman CE, Strom TB. Kirkman RL, et al. Among authors: ramos el. Transplant Proc. 1989 Feb;21(1 Pt 2):1766-8. Transplant Proc. 1989. PMID: 2652578 Clinical Trial. No abstract available.

2

A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation.

Kirkman RL, Shapiro ME, Carpenter CB, McKay DB, Milford EL, Ramos EL, Tilney NL, Waldmann TA, Zimmerman CE, Strom TB. Kirkman RL, et al. Among authors: ramos el. Transplantation. 1991 Jan;51(1):107-13. doi: 10.1097/00007890-199101000-00016. Transplantation. 1991. PMID: 1846250 Clinical Trial.

3

A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation.

Kirkman RL, Shapiro ME, Carpenter CB, McKay DB, Milford EL, Ramos EL, Tilney NL, Waldmann TA, Zimmerman CE, Strom TB. Kirkman RL, et al. Among authors: ramos el. Transplant Proc. 1991 Feb;23(1 Pt 2):1066-7. Transplant Proc. 1991. PMID: 1989150 Clinical Trial. No abstract available.

4

Ten-year experience with cyclosporine as primary immunosuppression in recipients of renal allografts.

Tilney NL, Chang A, Milford EL, Whitley WD, Lazarus JM, Ramos EL, Strom TB, Carpenter CB, Kirkman RL. Tilney NL, et al. Among authors: ramos el. Ann Surg. 1991 Jul;214(1):42-9. doi: 10.1097/00000658-199107000-00007. Ann Surg. 1991. PMID: 2064470 Free PMC article.

5

Decrease in phenotypically defined T helper inducer cells (T4+4B4+) and increase in T suppressor effector cells (T8+2H4+) in stable renal allograft recipients.

Ramos EL, Turka LA, Leggat JE, Wood IG, Milford EL, Carpenter CB. Ramos EL, et al. Transplantation. 1989 Mar;47(3):465-71. doi: 10.1097/00007890-198903000-00013. Transplantation. 1989. PMID: 2522253

6

In vivo anti-interleukin-2 receptor (anti-Tac) therapy is immunosuppressive, but not tolerogenic.

Ramos EL, Leggat JE, Milford EL, Kirkman RL, Tilney NL, Strom TB, Shapiro ME, Waldmann TA, Carpenter CB. Ramos EL, et al. Trans Assoc Am Physicians. 1989;102:231-9. Trans Assoc Am Physicians. 1989. PMID: 2534707 Clinical Trial. No abstract available.

7

Differential IL-2 receptor expression in renal allograft recipients treated with an anti-IL-2-receptor antibody.

Ramos EL, Milford EL, Kirkman RL, Tilney NL, Strom TB, Shapiro ME, Waldmann TA, Wood IG, Rollins MR, Carpenter CB. Ramos EL, et al. Transplantation. 1989 Sep;48(3):415-20. doi: 10.1097/00007890-198909000-00012. Transplantation. 1989. PMID: 2571203 Clinical Trial.

8

Prophylactic use of monoclonal anti-IL-2 receptor antibody in cadaveric renal transplantation.

Carpenter CB, Kirkman RL, Shapiro ME, Milford EL, Tiney NL, Waldmann TA, Zimmerman CE, Ramos EL, Strom TB. Carpenter CB, et al. Among authors: ramos el. Am J Kidney Dis. 1989 Nov;14(5 Suppl 2):54-7. Am J Kidney Dis. 1989. PMID: 2683758 Clinical Trial.

9

Antigen specificity of mixed lymphocyte response-induced suppressor cells.

Turka LA, Ramos EL, Leggat JE, Milford EL, Fraser PA, Carpenter CB. Turka LA, et al. Among authors: ramos el. Hum Immunol. 1987 Dec;20(4):293-306. doi: 10.1016/0198-8859(87)90020-6. Hum Immunol. 1987. PMID: 2449412

10

Delayed graft function is associated with an increased incidence of occult rejection and results in poorer graft survival.

Howard RJ, Pfaff WW, Brunson ME, Ramos EL, Peterson JC, Croker BP, Scornik JC, Parris CJ, Fennell RS. Howard RJ, et al. Among authors: ramos el. Transplant Proc. 1993 Feb;25(1 Pt 2):884. Transplant Proc. 1993. PMID: 8442256 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page